BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tong D, Zhang J, Wang X, Li Q, Liu LY, Yang J, Guo B, Ni L, Zhao L, Huang C. MeCP2 facilitates breast cancer growth via promoting ubiquitination-mediated P53 degradation by inhibiting RPL5/RPL11 transcription. Oncogenesis 2020;9:56. [PMID: 32483207 DOI: 10.1038/s41389-020-0239-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Wei C, Wu J, Liu W, Lu J, Li H, Hai B. Tripartite motif-containing protein 6 facilitates growth and migration of breast cancer through degradation of STUB1. Eur J Histochem 2021;65. [PMID: 33728863 DOI: 10.4081/ejh.2021.3214] [Reference Citation Analysis]
2 Ma X, Li Y, Zhao B. Ribosomal protein L5 (RPL5)/ E2F transcription factor 1 (E2F1) signaling suppresses breast cancer progression via regulating endoplasmic reticulum stress and autophagy. Bioengineered 2022;13:8076-86. [PMID: 35293275 DOI: 10.1080/21655979.2022.2052672] [Reference Citation Analysis]
3 Shen P, Wang Y, Chang H, Huang W, Lo C, Su Y, Yang J, Lin C, Dai Y. Developing a novel DNA methylation risk score for survival and identification of prognostic gene mutations in endometrial cancer: a study based on TCGA data. Japanese Journal of Clinical Oncology 2022. [DOI: 10.1093/jjco/hyac077] [Reference Citation Analysis]
4 Jafari H, Hussain S, Campbell MJ. Nuclear Receptor Coregulators in Hormone-Dependent Cancers. Cancers 2022;14:2402. [DOI: 10.3390/cancers14102402] [Reference Citation Analysis]
5 Wang L, Gao Y, Tong D, Wang X, Guo C, Guo B, Yang Y, Zhao L, Zhang J, Yang J, Qin Y, Liu L, Huang C. MeCP2 drives hepatocellular carcinoma progression via enforcing HOXD3 promoter methylation and expression through the HB-EGF/EGFR pathway. Mol Oncol 2021. [PMID: 34028973 DOI: 10.1002/1878-0261.13019] [Reference Citation Analysis]
6 Caron MMJ, Eveque M, Cillero-Pastor B, Heeren RMA, Housmans B, Derks K, Cremers A, Peffers MJ, van Rhijn LW, van den Akker G, Welting TJM. Sox9 Determines Translational Capacity During Early Chondrogenic Differentiation of ATDC5 Cells by Regulating Expression of Ribosome Biogenesis Factors and Ribosomal Proteins. Front Cell Dev Biol 2021;9:686096. [PMID: 34235151 DOI: 10.3389/fcell.2021.686096] [Reference Citation Analysis]
7 García-Cortés D, Hernández-Lemus E, Espinal-Enríquez J. Luminal A Breast Cancer Co-expression Network: Structural and Functional Alterations. Front Genet 2021;12:629475. [PMID: 33959148 DOI: 10.3389/fgene.2021.629475] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Wang S, Gan M, Chen C, Zhang Y, Kong J, Zhang H, Lai M. Methyl CpG binding protein 2 promotes colorectal cancer metastasis by regulating N6 -methyladenosine methylation through methyltransferase-like 14. Cancer Sci 2021;112:3243-54. [PMID: 34097350 DOI: 10.1111/cas.15011] [Cited by in F6Publishing: 1] [Reference Citation Analysis]